Thomas Fleming
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
- Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity
Papers in
-
- Advanced Glycation End Products research 8
-
- Biochemical Acid Research Studies 2
- Co-authors
- Peter P. Nawroth (21 shared papers)Jakob Morgenstern (8 shared papers)Thorsten Brenner (4 shared papers)Florian Uhle (4 shared papers)Hans‐Peter Hammes (5 shared papers)Sandro Altamura (2 shared papers)Martina Ulrike Muckenthaler (2 shared papers)Thomas M. Bruckner (3 shared papers)
- Journals
- Molecular Metabolism (4 papers)Experimental and Clinical Endocrinology & Diabetes (2 papers)Redox Biology (1 paper)Annals of Intensive Care (1 paper)BMC Endocrine Disorders (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Thomas Fleming
36 papers receiving 904 citations
Peers
Comparison fields: 5 of 104
- Clinical Biochemistry 62
- Endocrine and Autonomic Systems 60
- Critical Care and Intensive Care Medicine 40
- Aging 13
- Internal Medicine 20
Countries citing papers authored by Thomas Fleming
This map shows the geographic impact of Thomas Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fleming more than expected).
Fields of papers citing papers by Thomas Fleming
This network shows the impact of papers produced by Thomas Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fleming. The network helps show where Thomas Fleming may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 153 | |
| 2 | 2017 | 108 | |
| 3 | 2018 | 103 | |
| 4 | 2021 | 76 | |
| 5 | 2019 | 49 | |
| 6 | 2016 | 44 | |
| 7 | 2022 | 39 | |
| 8 | 1998 | 39 | |
| 9 | 2018 | 36 | |
| 10 | 2017 | 34 | |
| 11 | 2018 | 30 | |
| 12 | 2021 | 28 | |
| 13 | 2020 | 23 | |
| 14 | 2017 | 19 | |
| 15 | 2011 | 16 | |
| 16 | 2017 | 14 | |
| 17 | 2016 | 11 | |
| 18 | 2020 | 11 | |
| 19 | 2012 | 11 | |
| 20 | 2021 | 9 |
About Thomas Fleming
Thomas Fleming is a scholar working on Clinical Biochemistry, Biochemistry, Physiology, Endocrinology, Diabetes and Metabolism and Endocrine and Autonomic Systems, having authored 39 papers that have together received 919 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (8 papers), Natural Antidiabetic Agents Studies (3 papers), Dietary Effects on Health (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Biochemical Acid Research Studies (2 papers), Circadian rhythm and melatonin (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Clinical Biochemistry (62 citations), Endocrine and Autonomic Systems (60 citations), Critical Care and Intensive Care Medicine (40 citations), Aging (13 citations) and Internal Medicine (20 citations). Thomas Fleming has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Peter P. Nawroth, Jakob Morgenstern, Thorsten Brenner, Florian Uhle, Hans‐Peter Hammes, Sandro Altamura, Martina Ulrike Muckenthaler, Thomas M. Bruckner, Felix C. F. Schmitt and Stefan Hofer. Their work appears in journals such as Molecular Metabolism, Experimental and Clinical Endocrinology & Diabetes, Redox Biology, Annals of Intensive Care and BMC Endocrine Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.